168 related articles for article (PubMed ID: 18000379)
1. Non-random inactivation of large common fragile site genes in different cancers.
McAvoy S; Ganapathiraju SC; Ducharme-Smith AL; Pritchett JR; Kosari F; Perez DS; Zhu Y; James CD; Smith DI
Cytogenet Genome Res; 2007; 118(2-4):260-9. PubMed ID: 18000379
[TBL] [Abstract][Full Text] [Related]
2. Common fragile sites, extremely large genes, neural development and cancer.
Smith DI; Zhu Y; McAvoy S; Kuhn R
Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
[TBL] [Abstract][Full Text] [Related]
3. Disabled-1 is a large common fragile site gene, inactivated in multiple cancers.
McAvoy S; Zhu Y; Perez DS; James CD; Smith DI
Genes Chromosomes Cancer; 2008 Feb; 47(2):165-74. PubMed ID: 18008369
[TBL] [Abstract][Full Text] [Related]
4. DMD and IL1RAPL1: two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors.
McAvoy S; Ganapathiraju S; Perez DS; James CD; Smith DI
Cytogenet Genome Res; 2007; 119(3-4):196-203. PubMed ID: 18253029
[TBL] [Abstract][Full Text] [Related]
5. Differential loss of expression of common fragile site genes between oral tongue and oropharyngeal squamous cell carcinomas.
Soderberg C; Perez DS; Ukpo OC; Liang X; O'Reilly AG; Moore EJ; Kademani D; Smith DI
Cytogenet Genome Res; 2008; 121(3-4):201-10. PubMed ID: 18758160
[TBL] [Abstract][Full Text] [Related]
6. RORA, a large common fragile site gene, is involved in cellular stress response.
Zhu Y; McAvoy S; Kuhn R; Smith DI
Oncogene; 2006 May; 25(20):2901-8. PubMed ID: 16462772
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer.
Callahan G; Denison SR; Phillips LA; Shridhar V; Smith DI
Oncogene; 2003 Jan; 22(4):590-601. PubMed ID: 12555072
[TBL] [Abstract][Full Text] [Related]
8. Large common fragile site genes and cancer.
Smith DI; McAvoy S; Zhu Y; Perez DS
Semin Cancer Biol; 2007 Feb; 17(1):31-41. PubMed ID: 17140807
[TBL] [Abstract][Full Text] [Related]
9. The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers.
Blumrich A; Zapatka M; Brueckner LM; Zheglo D; Schwab M; Savelyeva L
Hum Mol Genet; 2011 Apr; 20(8):1488-501. PubMed ID: 21258086
[TBL] [Abstract][Full Text] [Related]
10. Evidence that instability within the FRA3B region extends four megabases.
Becker NA; Thorland EC; Denison SR; Phillips LA; Smith DI
Oncogene; 2002 Dec; 21(57):8713-22. PubMed ID: 12483524
[TBL] [Abstract][Full Text] [Related]
11. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
[TBL] [Abstract][Full Text] [Related]
12. Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region.
Bosco N; Pelliccia F; Rocchi A
Cancer Genet Cytogenet; 2010 Oct; 202(1):47-52. PubMed ID: 20804921
[TBL] [Abstract][Full Text] [Related]
13. A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas.
Gao G; Kasperbauer JL; Tombers NM; Wang V; Mayer K; Smith DI
Genes Chromosomes Cancer; 2014 May; 53(5):392-401. PubMed ID: 24481768
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer.
Sbrana I; Veroni F; Nieri M; Puliti A; Barale R
Genes Chromosomes Cancer; 2006 May; 45(5):429-36. PubMed ID: 16419058
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer.
Denison SR; Becker NA; Ferber MJ; Phillips LA; Kalli KR; Lee J; Lillie J; Smith DI; Shridhar V
Genes Chromosomes Cancer; 2002 Aug; 34(4):406-15. PubMed ID: 12112530
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of the human common fragile site FRA1H.
Curatolo A; Limongi ZM; Pelliccia F; Rocchi A
Genes Chromosomes Cancer; 2007 May; 46(5):487-93. PubMed ID: 17311248
[TBL] [Abstract][Full Text] [Related]
17. WWOX, large common fragile site genes, and cancer.
Gao G; Smith DI
Exp Biol Med (Maywood); 2015 Mar; 240(3):285-95. PubMed ID: 25595185
[TBL] [Abstract][Full Text] [Related]
18. Very large common fragile site genes and their potential role in cancer development.
Gao G; Smith DI
Cell Mol Life Sci; 2014 Dec; 71(23):4601-15. PubMed ID: 25300511
[TBL] [Abstract][Full Text] [Related]
19. WWOX, the tumour suppressor gene affected in multiple cancers.
Lewandowska U; Zelazowski M; Seta K; Byczewska M; Pluciennik E; Bednarek AK
J Physiol Pharmacol; 2009 May; 60 Suppl 1():47-56. PubMed ID: 19609013
[TBL] [Abstract][Full Text] [Related]
20. The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1.
Krummel KA; Denison SR; Calhoun E; Phillips LA; Smith DI
Genes Chromosomes Cancer; 2002 Jun; 34(2):154-67. PubMed ID: 11979549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
